News
>
Phase 3 clinical trial
Phase 3 clinical trial
Advertisement
Bharat Biotech's Covaxin shows 77.8 % efficacy in phase 3 data trial: Sources
1152748
1
0
topics
Subscribe Now
×
Enroll for our free updates
Please enter full name.
Please enter valid email address.
https://zeenews.india.com/
Subscribe Now
Thank you
NEWS ON ONE CLICK
)
